These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16188517)

  • 1. Use of combination evidence-based medical therapy prior to acute myocardial infarction (from the National Registry of Myocardial Infarction-4).
    Spencer FA; Frederick PD; Goldberg RJ; Gore JM; Tiefenbrunn AJ;
    Am J Cardiol; 2005 Oct; 96(7):922-6. PubMed ID: 16188517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value.
    Lee JH; Yang DH; Park HS; Cho Y; Jeong MH; Kim YJ; Kim KS; Hur SH; Seong IW; Hong TJ; Cho MC; Kim CJ; Jun JE; Park WH; Chae SC;
    Am Heart J; 2010 Jun; 159(6):1012-9. PubMed ID: 20569714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of early follow-up after acute myocardial infarction with higher rates of medication use.
    Daugherty SL; Ho PM; Spertus JA; Jones PG; Bach RG; Krumholz HM; Peterson ED; Rumsfeld JS; Masoudi FA
    Arch Intern Med; 2008 Mar; 168(5):485-91; discussion 492. PubMed ID: 18332293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of an anesthesia information system to identify and trend gender disparities in outpatient medical management of patients with coronary artery disease.
    Vigoda MM; Rodríguez LI; Wu E; Perry K; Duncan R; Birnbach DJ; Lubarsky DA
    Anesth Analg; 2008 Jul; 107(1):185-92. PubMed ID: 18635487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach.
    Zeymer U; Jünger C; Zahn R; Bauer T; Bestehorn K; Senges J; Gitt A
    Curr Med Res Opin; 2011 Aug; 27(8):1563-70. PubMed ID: 21682553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of the relationship between specialist training in cardiology and implementation of evidence-based care of patients following acute myocardial infarction.
    Dorsch MF; Lawrance RA; Sapsford RJ; Durham N; Das R; Jackson BM; Morrell C; Ball SG; Robinson MB; Hall AS;
    Int J Cardiol; 2004 Sep; 96(3):335-40. PubMed ID: 15301884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction.
    Wienbergen H; Zeymer U; Gitt AK; Juenger C; Schiele R; Heer T; Towae F; Senges J;
    Am J Cardiol; 2007 May; 99(9):1208-11. PubMed ID: 17478143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registry.
    Danchin N; Cambou JP; Hanania G; Kadri Z; Genès N; Lablanche JM; Blanchard D; Vaur L; Clerson P; Guéret P;
    Am Heart J; 2005 Dec; 150(6):1147-53. PubMed ID: 16338251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
    Anselmino M; Malmberg K; Ohrvik J; Rydén L;
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
    Ishii H; Ichimiya S; Kanashiro M; Aoyama T; Ogawa Y; Murakami R; Amano T; Naruse K; Matsubara T; Murohara T
    Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC; Tu JV; Ko DT; Alter DA
    CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based use of medications in patients with coronary artery disease in a rural Australian community.
    Granmyr J; Ball P; Curran S; Wang L
    Aust J Rural Health; 2007 Aug; 15(4):241-6. PubMed ID: 17617087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
    Bunch TJ; Muhlestein JB; Bair TL; Renlund DG; Lappé DL; Jensen KR; Horne BD; Carter MA; Anderson JL;
    Am J Cardiol; 2005 Apr; 95(7):827-31. PubMed ID: 15781009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
    Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of age on the use of evidence-based therapies for acute myocardial infarction.
    Tran CT; Laupacis A; Mamdani MM; Tu JV
    Am Heart J; 2004 Nov; 148(5):834-41. PubMed ID: 15523314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis.
    van der Elst ME; Bouvy ML; de Blaey CJ; de Boer A
    Clin Ther; 2005 Nov; 27(11):1806-14. PubMed ID: 16368451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing use of single and combination medical therapy in patients hospitalized for acute myocardial infarction in the 21st century: a multinational perspective.
    Goldberg RJ; Spencer FA; Steg PG; Flather M; Montalescot G; Gurfinkel EP; Kennelly BM; Goodman SG; Dedrick R; Gore JM;
    Arch Intern Med; 2007 Sep; 167(16):1766-73. PubMed ID: 17846396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of medication therapy discontinuation on mortality after myocardial infarction.
    Ho PM; Spertus JA; Masoudi FA; Reid KJ; Peterson ED; Magid DJ; Krumholz HM; Rumsfeld JS
    Arch Intern Med; 2006 Sep; 166(17):1842-7. PubMed ID: 17000940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term adherence with cardiovascular drug regimens.
    Kulkarni SP; Alexander KP; Lytle B; Heiss G; Peterson ED
    Am Heart J; 2006 Jan; 151(1):185-91. PubMed ID: 16368315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.